期刊文献+

Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer 被引量:3

Value of carcinoembryonic antigen and cytokeratins for the detection of recurrent disease following curative resection of colorectal cancer
暂未订购
导出
摘要 AIM: To evaluate the efficacy of postoperative serial assay of carcinoembryonic antigen (CEA) and cytokeratins for the detection of recurrent disease in patients with colorectal adenocarcinoma after radical surgery. METHODS: Between 1993 and 2000, 120 patients with colorectal adenocarcinoma underwent radical surgery in the Department of Surgical Gastroenterology, Federal University of Sao Paulo-Escola Paulista de Medicina, Sao Paulo, Brazil. Periodic postoperative evaluation was performed by assaying markers in peripheral serum, colonoscopy and imaging examination. Presence of CEA was detected using the Delfia^R method with 5 μg/L threshold, and cytokeratins using the LIA-mat TPA-M Prolifigen^R method with 72 U/L threshold. RESULTS: In the first postoperative year, patients without recurrent disease had normal levels of CEA (1.5 + 0.9μg/L) and monoclonal tissue polypeptide antigen-M (TPA-M, 64.4 ± 47.8 U/L), while patients with recurrences had high levels of CEA (6.9± 9.8 ;μg/L, P 〈 0.01) and TPA-M (192.2 ±328.8 U/L, P 〈 0.05). During the second postoperative year, patients without tumor recurrence had normal levels of CEA (2.0 ± 1.8μg/L) and TPA-M (50.8±38.4 U/L), while patients with recurrence had high levels of CEA (66.3 ±130.8 μg/L, P 〈 0.01) and TPA-M (442.7 ± 652.8 U/L, P 〈 0.05). The mean follow-up time was 22.3 mo. There was recurrence in 23 cases. Five reoperations were performed without achieving radical excision. Rises in tumor marker levels preceded identification of recurrences: CEA in seven (30%) and TPA-M in eleven individuals (48%). CONCLUSION: Intensive follow-up by serial assay of CEA and cytokeratins allows early detection of colorectal neoplasm recurrence. 瞄准:与颜色在病人为周期性的疾病的察觉评估 carcinoembryonic 抗原(CEA ) 和 cytokeratins 的手术后的连续试金的功效在激进的外科以后的表面的腺癌。方法:在 1993 和 2000 之间,有颜色的 120 个病人表面的腺癌在外科的肠胃病学的部门经历了激进的外科, Sao Paulo-Escola Paulista de Medicina 的联邦大学, Sao Paulo,巴西。周期的手术后的评估被 assaying 标记在外部浆液,结肠镜检查和成像检查执行。CEA 的存在与 72 U/L 阀值用 LIA 地席 TPA-M Prolifigen 方法与 5 microg/L 阀值,和 cytokeratins 用 Delfia 方法被检测。结果:在第一手术后的年里,没有周期性的疾病的病人有 CEA 的正常层次( 1.5 +/- 0.9 microg/L )并且单音的同种细胞的织物多肽 antigen-M ( TPA-M , 64.4 +/- 47.8 U/L ),当有复发的病人有 CEA 的高水平时( 6.9 +/- 9.8 microg/L , P < 0.01 )并且 TPA-M ( 192.2 +/- 328.8 U/L , P < 0.05 )。在第二手术后的年期间,没有肿瘤复发的病人有 CEA 的正常层次( 2.0 +/- 1.8 microg/L )并且 TPA-M ( 50.8 +/- 38.4 U/L ),当有复发的病人有 CEA 的高水平时( 66.3 +/- 130.8 microg/L , P < 0.01 )并且 TPA-M ( 442.7 +/- 652.8 U/L , P < 0.05 )。吝啬的后续时间是 22.3 瞬间。在 23 种情况中有复发。没有完成激进的切除,五个手术被动。在肿瘤标记层次的上升先于复发的鉴定:在七的 CEA (30%) 和在十一个个人(48%) 的 TPA-M。结论:由 CEA 和 cytokeratins 的连续试金的集中的后续允许颜色的早察觉表面的瘤复发。
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2006年第24期3891-3894,共4页 世界胃肠病学杂志(英文版)
基金 Supported by Foundation for Research Support of the State of Sao Paulo-FAPESP, No. 98/12504-1
关键词 Colorectal neoplasms CYTOKERATIN Carcin-oembryonic antigen Residual neoplasm 细胞角蛋白 药物治疗 直肠癌 结肠癌
  • 相关文献

参考文献2

二级参考文献27

  • 1Hong-ZhiWang Xin-FuHuang Yiwang Jia-FuJi JinGu.Clinical features,diagnosis,treatment and prognosis of multiple primary colorectal carcinoma[J].World Journal of Gastroenterology,2004,10(14):2136-2139. 被引量:44
  • 2Pence BC. Role of calcium in colon cancer prevention: experimental and clinical studies. Mutat Res 1993; 290:87-95.
  • 3Buras RR, Shabahang M, Davoodi F, Schumaker LM, Cullen KJ,Byers S, Nauta RJ, Evans SR. The effect of extracellular calcium on colonocytes: evidence for differential responsive based upon degree of cell differentiation. Cell Profil 1995; 28:245-262.
  • 4Greenwald PJ. Cancer risk factors for selecting cohorts for largescale chemoprevention trials. Cell Biochem Suppl 1996; 25:29-36.
  • 5Lipkin M. New rodent models for studies of chemopreventive agents. J Cell Biochem Suppl 1997; 28-29:144-147.
  • 6Lipkin M, Newmark H. Calcium and the prevention of colon cancer. J Cell Biochem Suppl 1995; 22:65-73.
  • 7Bostick RM. Human studies of calcium supplementation and colorectal epithelial cell proliferation. Cancer Epidemiol Biomarkers Prev 1997; 11:971-980.
  • 8Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK,Gorham ED. Serum 25-hydroxyvitamin D and colon cancer: eightyear prospective study. Lancet 1989; 2:1176-1178.
  • 9Holt PR, Atillasoy EO, Gilman J, Guss J, Moss SF, Newmark H,Fan K, Yang K, Lipkin M. Modulation of abnormal colonic epithelial cell proliferation and differentiation by low-fat dairy foods:a randomized controlled trial. JAMA 1998; 12:1074-1079.
  • 10Pence BC, Buddingh F. Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3.Carcinogenesis 1988; 1:187-190.

共引文献24

同被引文献4

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部